Ontology highlight
ABSTRACT:
SUBMITTER: Ribaldone DG
PROVIDER: S-EPMC6832711 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
Ribaldone Davide Giuseppe DG Caviglia Gian Paolo GP Abdulle Amina A Pellicano Rinaldo R Ditto Maria Chiara MC Morino Mario M Fusaro Enrico E Saracco Giorgio Maria GM Bugianesi Elisabetta E Astegiano Marco M
Journal of clinical medicine 20191009 10
The response to treatment with biologic drugs, in patients with Crohn's disease, could be associated with changes in gut microbiota composition. The aim of our study was to analyse the modification of microbiota during adalimumab therapy in patients with Crohn's disease. We performed a prospective study in patients with Crohn's disease analysing gut microbiota before start of adalimumab therapy (T0) and after six months of therapy (T1). Among the 20 included patients, the phylum <i>Proteobacteri ...[more]